Selected data models

You must log in to select data models for download or further analysis.

7 Search results.
Relevance Rating New first Old first

Critical Care case record form (EuSOS)

- 9/20/21 - 1 form, 3 itemgroups, 81 items, 1 language
Itemgroups: Data describing first hour of admission to critical care, Surgical site, Highest vasoactive drug dose in the first hour following admission
European Surgical Outcomes Study (EuSOS) http://clinicaltrials.gov/show/NCT01203605

Item List ICM UKB Maßnahmen Part 3

- 9/17/21 - 1 form, 1 itemgroup, 1001 items, 2 languages
Itemgroup: Maßnahmen Part 3
ICM Item list, which is in use in Intensive Care at the University Hospital Bonn, Germany. Permission granted by Dr. Zenker.

ISARIC/WHO Novel Coronavirus (nCoV) / COVID-19 Case Report Form - COVID-19 Case Report Form Rapid Critical Care Module - Part B

- 2/18/21 - 1 form, 6 itemgroups, 96 items, 1 language
Itemgroups: Participant Identification Numbers, ICU/HDU Admission Form, Reason for ICU admission, Fraility and renal failure, Daily form, Current treatment
To be completed for patients receiving critical care on whom the data below are available, together with the RAPID CRF. RAPID COVID-19 CRF users: - Sites should select whether they complete Part A only or both Parts A & B where resources allows. - In addition always complete the RAPID CRF Module 1 on day of admission to the hospital. For patients receiving critical care complete: - Part A - Complete on every day for patients receiving critical care beginning on the day of admission to an intensive care / high dependency unit, or on the first day of deterioration to severe disease in any ward where the data below is available. Complete daily for as many days as resources allow. In addition, complete the RAPID CRF Module 2 (Daily Form). - Part B - Complete Section 1 on the day of admission to an intensive care / high dependency unit. Complete Section 2 every day during critical care. In addition, complete the RAPID CRF Module 2 (Daily Form). - Complete the RAPID CRF Module 3 on death or hospital discharge for all patients.

ISARIC/WHO Novel Coronavirus (nCoV) / COVID-19 Case Report Form - COVID-19 Case Report Form Rapid Critical Care Module - Part A

- 2/18/21 - 1 form, 3 itemgroups, 34 items, 1 language
Itemgroups: Participant Identification Numbers, Current treatment, Signs and Symptoms
To be completed for patients receiving critical care on whom the data below are available, together with the RAPID CRF. RAPID COVID-19 CRF users: - Sites should select whether they complete Part A only or both Parts A & B where resources allows. - In addition always complete the RAPID CRF Module 1 on day of admission to the hospital. For patients receiving critical care complete: - PART A - Complete on every day for patients receiving critical care beginning on the day of admission to an intensive care / high dependency unit, or on the first day of deterioration to severe disease in any ward where the data below is available. Complete daily for as many days as resources allow. In addition, complete the RAPID CRF Module 2 (Daily Form). - PART B - Complete Section 1 on the day of admission to an intensive care / high dependency unit. Complete Section 2 every day during critical care. In addition, complete the RAPID CRF Module 2 (Daily Form). - Complete the RAPID CRF Module 3 on death or hospital discharge for all patients.

Eligibility Antibiotics in Critical Care Patients DRKS00004426 NCT01793012 DRKS00004426 - Eligibility Antibiotics in Critical Care Patients NCT01793012 DRKS00004426

- 6/26/17 - 1 form, 2 itemgroups, 12 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Responsible Party: Michael Zoller MD, senior physician, Ludwig-Maximilians - University of Munich ClinicalTrials.gov Identifier: NCT01793012 History of Changes Other Study ID Numbers: MUC 428-12 DRKS00004426 ( Other Identifier: German clinical trials register ) Study First Received: January 24, 2013 Last Updated: March 30, 2015 Drug Monitoring of Antibiotics in Critical Care Patients (DRAK) ODM derived from: https://clinicaltrials.gov/ct2/show/NCT01793012

Eligibility Acute Heart Failure NCT01301313

- 12/4/15 - 1 form, 2 itemgroups, 9 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Efficacy and Safety of Levosimendan in Severe Acute Heart Failure in Critical Children; ODM derived from: https://clinicaltrials.gov/show/NCT01301313

Critical care discharge data (EuSOS)

- 9/29/14 - 1 form, 1 itemgroup, 7 items, 1 language
Itemgroup: Critical care discharge
European Surgical Outcomes Study (EuSOS) http://clinicaltrials.gov/show/NCT01203605

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial